I was careless in my speech. I should have said I bumped-up my buy price, because I entered the buy at the Ask. (But I did get favorable slippage again).
I think we'll regain Nasdaq compliance with Baudax as a combined company. So maybe a ticker change, maybe not. But it's confusing, because I think a deal could still include PCI Pharma, too.
In and out of merger subs. Maybe maintaining 20% +18% +18% = 56% of HGEN, and 22% each of Baudax and PCI.
It will probably make the guys laugh to see how confused they have gotten me. But even more, I think we will somehow cash in on 110M FTD's, and work in a 5:1 forward stock split, too.